Venn Mapping: clustering of heterologous microarray data based on the number of co-occurring differentially expressed genesSMID, Marcel; DORSSERS, Lambert C. J; JENSTER, Guido et al.Bioinformatics (Oxford. Print). 2003, Vol 19, Num 16, pp 2065-2071, issn 1367-4803, 7 p.Article

Gene expression of forkhead transcription factors in the normal and diseased human prostateVAN DER HEUL-NIEUWENHUIJSEN, Leonie; DITS, Natasja F; JENSTER, Guido et al.BJU international (Papier). 2009, Vol 103, Num 11, pp 1574-1580, issn 1464-4096, 7 p.Article

Screening for Prostate Cancer in 2008 II: The Importance of Molecular Subforms of Prostate-Specific Antigen and Tissue KallikreinsJANSEN, Flip H; ROOBOL, Monique; JENSTER, Guido et al.European urology. 2009, Vol 55, Num 3, pp 563-574, issn 0302-2838, 12 p.Article

Protein chip technology reveals distinctive protein expression profiles in the urine of bladder cancer patients. CommentaryMUELLER, J; VON EGGELING, F; DRIESCH, D et al.European urology. 2005, Vol 47, Num 6, pp 885-894, issn 0302-2838, 10 p.Article

Identification of leptomeningeal metastasis-related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI-TOF, MALDI-FTICR and nanoLC-FTICR MSRÖMPP, Andreas; DEKKER, Lennard; TABAN, Ioana et al.Proteomics (Weinheim. Print). 2007, Vol 7, Num 3, pp 474-481, issn 1615-9853, 8 p.Article

Activin A Stimulates AKR1C3 Expression and Growth in Human Prostate CancerHOFLAND, Johannes; VAN WEERDEN, Wytske M; STEENBERGEN, Jacobie et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 12, pp 5726-5734, issn 0013-7227, 9 p.Article

Androgen Regulation of micro-RNAs in Prostate CancerWALTERING, Kati K; PORKKA, Kati P; JALAVA, Sanni E et al.The Prostate. 2011, Vol 71, Num 6, pp 604-614, issn 0270-4137, 11 p.Article

Truncated ETV1, Fused to Novel Tissue-Specific Genes, and Full-Length ETV1 in Prostate CancerHERMANS, Karin G; VAN DER KORPUT, Hetty A; KORSTEN, Hanneke et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 18, pp 7541-7549, issn 0008-5472, 9 p.Article

Long Noncoding RNA in Prostate, Bladder, and Kidney CancerMARTENS-UZUNOVA, Elena S; BOTTCHER, René; CROCE, Carlo M et al.European urology. 2014, Vol 65, Num 6, pp 1140-1151, issn 0302-2838, 12 p.Article

Inhibition of Androgen Receptor Functions by Gelsolin FxxFF Peptide Delivered byTransfection, Cell-Penetrating Peptides, and Lentiviral InfectionVAN DE WIJNGAART, Dennis J; DUBBINK, Hendrikus J; MOLIER, Michel et al.The Prostate. 2011, Vol 71, Num 3, pp 241-253, issn 0270-4137, 13 p.Article

Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate CancerHERMANS, Karin G; BOORMANS, Joost L; GASI, Delila et al.Clinical cancer research (Print). 2009, Vol 15, Num 20, pp 6398-6403, issn 1078-0432, 6 p.Article

Differential expression of protease activity in serum samples of prostate carcinoma patients with metastasesDEKKER, Lennard J. M; BURGERS, Peter C; CHARIF, Halima et al.Proteomics (Weinheim. Print). 2010, Vol 10, Num 12, pp 2348-2358, issn 1615-9853, 11 p.Article

TMPRSS2:ERG fusion by translocation or interstitial deletion is highly relevant in androgen-dependent prostate cancer, but is bypassed in late-stage androgen receptor-negative prostate cancerHERMANS, Karin G; VAN MARION, Ronald; VAN DEKKEN, Herman et al.Cancer research (Baltimore). 2006, Vol 66, Num 22, pp 10658-10663, issn 0008-5472, 6 p.Article

Androgen receptor modifications in prostate cancer cells upon long-term androgen ablation and antiandrogen treatmentMARQUES, Rute B; ERKENS-SCHULZE, Sigrun; DE RIDDER, Corrina M et al.International journal of cancer. 2005, Vol 117, Num 2, pp 221-229, issn 0020-7136, 9 p.Article

A 36-gene Signature Predicts Clinical Progression in a Subgroup of ERG-positive Prostate CancersTANDEFELT, Delila Gasi; BOORMANS, Joost L; VAN DER KORPUT, Hetty A et al.European urology. 2013, Vol 64, Num 6, pp 941-950, issn 0302-2838, 10 p.Article